Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GEMCITABINE HYDROCHLORIDE USP, with a corresponding US DMF Number 22800.
Remarkably, this DMF maintains an Active status since its submission on May 16, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on November 16, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II